financetom
Business
financetom
/
Business
/
Cipher Mining Stock Soars On PIPE Investment From SoftBank
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cipher Mining Stock Soars On PIPE Investment From SoftBank
Jan 30, 2025 2:43 PM

Cipher Mining Inc ( CIFR ) shares are surging in Thursday’s after-hours session after the company announced a $50 million PIPE investment from SoftBank.

What Happened: Bitcoin (CRYPTO: BTC) miner Cipher Mining ( CIFR ) has received a $50 million investment from SoftBank to support the company’s high-performance computing (HPC) data center development business. The PIPE investment also establishes SoftBank as a primary investor in Cipher.

“We are thrilled to welcome SoftBank as an important investor in Cipher. This investment comes at a pivotal moment in Cipher’s growth trajectory, as the Company continues to attract attention for its pipeline of sites and innovative solutions in industrial-scale data centers,” said Tyler Page, CEO of Cipher Mining ( CIFR ).

“SoftBank’s focus on innovation in technology and AI development aligns with our vision to establish ourselves as a leader in HPC data center development.”

Cipher provided an operational update at the beginning of January, noting that it mined 234 Bitcoin in December and ended the month with an operating hashrate of 13.5 EH/s.

Cipher focuses on the development and operation of industrial-scale data centers for Bitcoin mining and HPC hosting. 

CIFR Price Action: Cipher Mining ( CIFR ) shares were up 17.02% after hours, trading at $5.50 at the time of publication Thursday, according to Benzinga Pro.

See Also:

Bitcoin, Ethereum, XRP, Dogecoin Gain Momentum Ahead Of Weekend As Bulls Eye Profitable February

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hormel Foods' FY24 Outlook Takes A Hit Amid Production Disruptions, Stock Plummets
Hormel Foods' FY24 Outlook Takes A Hit Amid Production Disruptions, Stock Plummets
Sep 4, 2024
Hormel Foods Corporation ( HRL ) shares are trading lower on Wednesday following a revised fiscal year 2024 outlook due to production disruptions. The company reported third-quarter adjusted earnings per share of 37 cents, beating the analyst consensus of 36 cents. Quarterly sales of $2.898 billion (down 2.2%) missed the street view of $2.95 billion. Adjusted operating margin in the...
Cathay Pacific A350 fleet to resume full service by Saturday after repairs
Cathay Pacific A350 fleet to resume full service by Saturday after repairs
Sep 4, 2024
* All Cathay's A350s expected to resume service by Saturday * Source says leaking fuel system may have caused engine fire * Engine maker Rolls-Royce has not ordered fleet-wide inspection Some Asian A350 operators inspecting engines, carriers say * 15 A350s need fuel line repairs, Cathay says (Recasts, adds other airlines) By Lisa Barrington Sept 4 (Reuters) - Cathay Pacific...
SocGen Previews Wednesday's Bank of Canada Policy Meeting
SocGen Previews Wednesday's Bank of Canada Policy Meeting
Sep 4, 2024
07:30 AM EDT, 09/04/2024 (MT Newswires) -- The Bank of Canada is set to deliver its third successive quarter-point rate cut on Wednesday at 9:45 a.m. ET, said Societe Generale. The Canadian economy expanded by 2.1% seasonally adjusted annual rate (SAAR) in Q2, but inflation eased to 2.5% y/y in July and the unemployment rate has climbed to 6.4%, noted...
Merck, EyeBio Begin Phase 2b/3 Trial for Restoret
Merck, EyeBio Begin Phase 2b/3 Trial for Restoret
Sep 4, 2024
07:23 AM EDT, 09/04/2024 (MT Newswires) -- Merck ( MRK ) and subsidiary EyeBio said Wednesday they initiated the phase 2b/3 trial evaluating the investigational therapy Restoret for the treatment of diabetic macular edema. Diabetic macular edema is an eye condition triggered by diabetes that could lead to blindness. Data from the Phase 1/2 AMARONE study provided early evidence for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved